Intensive insulin therapy in patients with type 2 diabetes

The Lancet

Volumn 372, Issue 9640, 2008, Pages 717-

  DeVries, J Hans ^a   Siegelaar, Sarah ^a   Holleman, Frits ^a   Hoekstra, Joost B ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

AUTOIMMUNE DISEASE; BODY MASS; HUMAN; HYPERGLYCEMIA; LETTER; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; ATTITUDE TO HEALTH; DIABETIC DIET; EXERCISE; NOTE; WEIGHT REDUCTION;

DIABETES MELLITUS, TYPE 2; DIABETIC DIET; EXERCISE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; WEIGHT LOSS;

EID: 50149116384     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61302-1     Document Type: Letter

References (2)

1. Weng J., Li Y., Xu W., et al. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 371 (2008) 1753-1760
2. Nathan D.M., Buse J.B., Davidson M.B., et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49 (2006) 1711-1721